Dr. Gaston De Serres is an epidemiologist practitioner at the l’Institut national de santé publique du Québec and a regular researcher in the Infectious and Immune Disease Axis at the CHU de Québec-Laval University. He is a full professor in epidemiology in the Department of social and preventive medicine at Laval University where he has been teaching since 1997. He is chief physician of the scientific immunization group (SIG) of the Institut national de santé publique du Québec and an active member of the Comité sur l’immunisation du Québec (CIQ).

Dr. De Serre works on the control and prevention of infectious diseases, with a focus on diseases that are avoidable through vaccination and on respiratory diseases. His research work is on the epidemiology of diseases that are preventable through vaccination and the efficacy of vaccinations used in routine programs, and in particular, on the efficacy of the influenza vaccine.

2400, avenue d'Estimauville, 3e étage
Québec, Québec
Canada G1E 7G9
+1 418-666-7000, extension 274
+1 418-666-2776

Latest news

295 entries « ‹ 1 of 59 › »

Skowronski DM, Chambers C, De Serres G, Sabaiduc S, Winter AL, Dickinson JA, Gubbay JB, Drews SJ, Fonseca K, Charest H, Martineau C, Hickman R, Chan T, Jassem A, Petric M, Rose C, Bastien N, Li Y, Krajden M

Vaccine effectiveness against lineage matched and mismatched influenza B viruses across 8 seasons in Canada, 2010-11 to 2017-18.

Journal Article

Clin Infect Dis, 2018, ISSN: 1058-4838.

Abstract | Links:

Kiely M, Billard MN, Toth E, Zafack JG, Landry M, Skowronski DM, De Serres G

Investigation of an increase in large local reactions following vaccine schedule change to include DTaP-HB-IPV-Hib (Infanrix-hexa(R)) and MMRV (ProQuad(R)) at 18months of age.

Journal Article

Vaccine, 2018, ISSN: 0264-410X.

Abstract | Links:

Gilca V, Sauvageau C, Panicker G, De Serres G, Ouakki M, Unger ER

Antibody persistence after a single dose of quadrivalent HPV vaccine and the effect of a dose of nonavalent vaccine given 3-8 years later - an exploratory study.

Journal Article

Hum Vaccin Immunother, pp. 1-5, 2018.

Abstract | Links:

Zafack JG, Toth E, Landry M, Drolet JP, Top KA, De Serres G

Rate of Recurrence of Adverse Events Following Immunization: Results of 19 Years of Surveillance Ii Quebec, Canada.

Journal Article

Pediatr Infect Dis J, 2018, ISSN: 0891-3668.

Abstract | Links:

Carazo Perez S, Bureau A, De Serres G

Post-immunisation fever and the antibody response to measles-containing vaccines.

Journal Article

Epidemiol Infect, 146 (12), pp. 1584-1592, 2018, ISSN: 0950-2688.

Abstract | Links:

295 entries « ‹ 1 of 59 › »

Active projects

  • Centre hospitalier universitaire de Québec - CHU de Québec-Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31
  • CV04 QC03 - CANVAS Network - Surveillance of adverse events following immunization among children and adults immunized with the influenza vaccine, Subvention, Instituts de recherche en santé du Canada, Réseau canadien de recherche sur l’immunisation, from 2017-06-01 to 2022-03-31
  • Interchangeabilité des vaccins VPH., Subvention, Ministère de la Santé et des Services sociaux, from 2011-03-29 to 2019-12-31

Recently finished projects

  • Canadian Immunization Research Network, Subvention, Instituts de recherche en santé du Canada, Réseau canadien de recherche sur l’immunisation, from 2014-06-01 to 2017-05-31
  • Canadian National Vaccine Safety (CANVAS) network : Surveillance of Adverse Events Following Immunization among Children and Adults Immunized with the Influenza Vaccine (CV01 QC03), Subvention, Instituts de recherche en santé du Canada, Réseau canadien de recherche sur l’immunisation, from 2015-04-01 to 2017-03-31
  • PHAC / CIHR Influenza Research Network, Subvention, Instituts de recherche en santé du Canada, from 2012-06-01 to 2018-03-31
Data provided by the Université Laval research projects registery